Key Technology Announces Fiscal 2017 Third Quarter Financial Results
Jul 27, 2017 20:10 pm UTC| Business
WALLA WALLA, Wash., July 27, 2017 -- Key Technology, Inc. (NASDAQ:KTEC) announced today sales and operating results for its fiscal 2017 third quarter, ended June 30, 2017. Third Quarter OverviewNet sales for the three...
Jones Soda Announces Second Quarter Fiscal 2017 Earnings Conference Call
Jul 27, 2017 20:10 pm UTC| Business
Seattle, WA, July 27, 2017 -- Jones Soda Co. (OTCQB: JSDA), a leader in the premium soda category and known for its unique branding and innovative marketing, today announced that it will host a conference...
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 27, 2017 20:09 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., July 27, 2017 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on July 25, 2017, the Compensation Committee of the Board of Directors approved, effective as of July 31,...
LogMeIn Announces Second Quarter 2017 Results
Jul 27, 2017 20:08 pm UTC| Business
BOSTON, July 27, 2017 -- LogMeIn, Inc. (NASDAQ:LOGM), a leading provider of cloud-based connectivity, today announced its results for the second quarter ended June 30, 2017. Second quarter 2017 highlights include: ...
VASCO Names Scott Clements Chief Executive Officer
Jul 27, 2017 20:07 pm UTC| Business
OAKBROOK TERRACE, Ill., and ZURICH, Switzerland, July 27, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity, today...
Cerner Reports Second Quarter 2017 Results
Jul 27, 2017 20:06 pm UTC| Business
KANSAS CITY, Mo., July 27, 2017 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2017 second quarter that ended July 1, 2017. Bookings in the second quarter of 2017 were $1.636 billion, which is an...
Ultragenyx Reports Second Quarter 2017 Financial Results and Corporate Update
Jul 27, 2017 20:06 pm UTC| Business
NOVATO, Calif., July 27, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...